MARK A. GOLDSMITH - President and Chief Executive Officer, Director at Revolution Medicines, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and Chief Executive Officer, Director
Issuer Symbol
RVMD, RVMDW on Nasdaq
All Insider Reports
All Insider Reports

MARK A. GOLDSMITH - trading volume in the past year for Revolution Medicines, Inc.

Holdings reported by MARK A. GOLDSMITH for Revolution Medicines, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 570,050 $41,989,883 $73.66 16 Dec 2025 Trust
Common Stock 232,469 $17,857,640 $76.82 16 Dec 2025 Direct
Stock Option (Right to Buy) 77,708 25 Nov 2025 Direct Common Stock

Transactions reported by MARK A. GOLDSMITH for Revolution Medicines, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.